about
Silk as an innovative biomaterial for cancer therapyFunctionalized bioengineered spider silk spheres improve nuclease resistance and activity of oligonucleotide therapeutics providing a strategy for cancer treatment.Cell-based Hyper-interleukin 6 or Hyper-interleukin 11 secreting vaccines combined with low dose cyclophosphamide in an orthotopic murine prostate cancer model.Heterotypic breast cancer model based on a silk fibroin scaffold to study the tumor microenvironment.Oncogenic BRAF mutations and p16 expression in melanocytic nevi and melanoma in the Polish population.Whole cell melanoma vaccine genetically modified to stem cells like phenotype generates specific immune responses to ALDH1A1 and long-term survival in advanced melanoma patientsCellular Vaccines Modified with Hyper IL6 or Hyper IL11 Combined with Docetaxel in an Orthotopic Prostate Cancer Model
P50
Q35113124-AD2F8510-C7B1-4319-A02B-1D6BFE2042AAQ38287775-F13455DE-ED5F-4CDA-8C75-83AC3BA11789Q43190686-9D62F441-1B10-4EEC-8E32-FF4A1B81BCC5Q50043000-BD294843-128E-4D35-BB2F-44FB09D10BEEQ55261258-BA6F5612-2AAD-4B3F-AABE-775DB29B638BQ58129598-DB2F4153-7F0F-4C14-B5A5-7AF5656B6973Q85260210-51D18C2A-419A-429E-867A-5D5F4023E544
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Ewelina Dondajewska
@en
Ewelina Dondajewska
@nl
type
label
Ewelina Dondajewska
@en
Ewelina Dondajewska
@nl
prefLabel
Ewelina Dondajewska
@en
Ewelina Dondajewska
@nl
P31
P496
0000-0001-9078-2015